| Andrew Retter |
Andrew Retter is currently the Chief Medical Officer at VolitionRX Ltd. He obtained his doctorate degree from St Georges Hospital Medical School in 2001. |
| Terig Hughes |
Terig Hughes is currently the Director at Singapore Volition Pte Ltd., Director at Volition Global Services SRL, Chief Financial Officer & Treasurer at VolitionRX Ltd., Chief Financial Officer & Treasurer at Volition America, Inc., and Chief Financial Officer & Treasurer at Volition Veterinary Diagnostics Development LLC. Previously, he worked as the Managing Director-India & Southeast Asia at RELX Group Plc from 2014 to 2017, Vice President-Finance at Elsevier, Inc. from 2003 to 2006, and Chief Financial Officer at AUM Biosciences Pte Ltd. from 2018 to 2020. He completed his undergraduate and graduate degrees at De Montfort University. |
| Gael Forterre |
Gael Forterre is the founder of Article 22 LLC, which was founded in 2013. He held the title of Director at Article 22 LLC from 2013 to 2021. Mr. Forterre is currently a Director at Ucroo, Inc. since 2017, Chief Commercial Officer at VolitionRX Ltd. since 2021, and Managing Partner at Armori Capital Management LLC since 2013. In his former positions, Mr. Forterre was the Chief Executive Officer at PATH, Inc. from 2019 to 2020 and an Independent Non-Executive Director at Integrated Wellness Acquisition Corp. He also served as a Director at Path Education, Inc. Mr. Forterre has an MBA from London Business School, a graduate degree from Paris-Sorbonne University Abu Dhabi, and an MBA from Columbia Business School. |
| Martin C. Faulkes |
Martin C. Faulkes was the founder of Triad Group Plc, founded in 1987, where he served as Director from 1987 to 1998. He is also the founder of Dill Faulkes Educational Trust, founded in 1998, where he currently holds the title of Chairman. Additionally, he was the founder of Logica, Inc., founded in 1979, where he served as President & Chief Executive Officer from 1979 to 1984. Dr. Faulkes currently holds the position of Executive Chairman at VolitionRX Ltd. since 2011. He also serves as Executive Chairman at Volition America, Inc. since 2011. Furthermore, he holds the position of Director-800th Anniversary Campaign at the University of Cambridge and Non-Executive Director at Blue Skies Space Ltd. In his former roles, Dr. Faulkes served as Executive Chairman at Singapore Volition Pte Ltd. from 2010 to 2015. He was also a Director at Belgian Volition SRL from 2011 to 2016. Prior to that, he held the position of Managing Director at System Programming Ltd. from 1985 to 1987. Most recently, he served as President & Manager at Volition Veterinary Diagnostics Development LLC from 2019 to 2021. Dr. Faulkes obtained a doctorate degree from Queen Elizabeth College and an undergraduate degree from The University of Hull. |
| Gaetan Michel |
Gaetan Michel is currently the Chief Executive Officer & Director at Volition America, Inc., the Chief Executive Officer & Manager at Volition Global Services SRL, the Chief Operating Officer at VolitionRX Ltd., and the President at Volition Veterinary Diagnostics Development LLC. Previously, he held positions as the Chief Executive Officer at Belgian Volition SRL from 2018 to 2020, the Production Director at Bone Therapeutics SA from 2010 to 2014, and the Managing Director at Volition Germany GmbH from 2020 to 2021. He also worked as a Principal at KitoZyme NV from 2007 to 2013, a Project Manager at Proteomics, Inc., and a Production Manager at Advanced Array Technology SA from 2013 to 2014. Dr. Michel completed his undergraduate and graduate degrees at the University of Namur. |
| Terry Kelly |
Terry Kelly is currently the Chief Innovation Officer at VolitionRX Ltd. Prior to this, she worked as the Director of Research and Development at Active Motif, Inc. Ms. Kelly holds a doctorate degree from the University of California, Los Angeles. |
| Mark Eccleston |
Mark Eccleston was the founder of Vivamer Ltd. (founded in 2002) and held the title of Chief Scientific Officer from 2002 to 2006. He is currently the Director of Business Development at Volition, Inc., the Managing Director at Oncolytika Ltd. (since 2010), and the Chief Technology Officer at VolitionRX Ltd. Dr. Eccleston's former job was as the Director of ADD Signs Ltd. (2010-2017). He obtained an MBA from the University of Dundee in 2008 and a doctorate from the University of Aston in 1998. |
| Jacob Vincent Micallef |
Jacob Vincent Micallef was the founder of Belgian Volition SRL, founded in 2010, where he held the title of Director, Chief Executive & Scientific Officer from 2011 to 2016. He was also the founder of Gene Expression Technologies Ltd., founded in 1999, where he held the title of Director. Dr. Micallef is currently the Chief Scientific Officer at VolitionRX Ltd. since 2015. He previously worked as the Chief Technical Officer at ValiRx Plc from 2006 to 2010. Dr. Micallef's education includes an undergraduate degree and a doctorate from King's College London, an MBA from Imperial College Business School, and a graduate degree from St Thomas Hospital Medical School. Dr. Micallef is also the founder of World Health Organization, Immunometrics (UK) Ltd., Valipharma Ltd... |
| Louise Batchelor |
Louise Batchelor is currently the Director & Owner at Aculd Ltd. since 2011 and the Chief Marketing & Communications Officer at VolitionRX Ltd. since 2016. Previously, she worked as the Manager-Global Brand Marketing at Reckitt Benckiser Ltd. from 2001 to 2009 and as a Sales Manager at Zeneca Pharmaceuticals from 1993 to 2000. She completed her undergraduate degree at Sheffield Hallam University in 1993. |
| Cameron John Reynolds |
Cameron John Reynolds is currently the President, Chief Executive Officer & Director at VolitionRX Ltd., the Chief Executive Officer & Director at Hypergenomics Pte Ltd., the President, Group CEO & Director at Volition America, Inc., the Director at Belgian Volition SRL, the Non-Executive Director at Ucroo, Inc., the Director at Pathify Holdings, Inc., the Director at Path Education, Inc., the Non-Executive Director at GlycanAge Ltd., and the Manager at Volition Veterinary Diagnostics Development LLC. Previously, he held positions as the Chief Executive Officer & Director at Volition Diagnostics UK Ltd., the Director at KAL Energy, Inc., the Commercialization Director at ProBio, Inc., the Independent Non-Executive Director at Wellfully Ltd., the Director at Searchlight Resources, Inc., the Managing Director & Director at Mining House Ltd., the Director at Magellan Copper & Gold Plc, the Director at Carbon Mining Plc, the Director at Hunter Bay Resources, Inc., the Director at Iofina Natural Gas, Inc., the Director at Singapore Volition Pte Ltd., the Director at Atlantic Mining Plc, the Chief Financial Officer at Aberdene Mines Ltd., and the Regional Manager at South China Group Holdings Ltd. He obtained an MBA from The University of Western Australia in 2003 and an undergraduate degree from the same institution in 1993. |
| Phillip Barnes |
Phillip Barnes is an Independent Director at VolitionRX Ltd. and Volition America, Inc. He previously served as an Executive Medical Director at the United Kingdom Department of Health & Social Care, the National Health Service, the National Health Foundation Service Trust, and the Medway NHS Foundation Trust. He holds a doctorate degree from the University of Oxford and undergraduate and doctorate degrees from the University of London. |
| Alan Colman |
Alan Colman is currently an Independent Director at VolitionRX Ltd., an Independent Director at Volition America, Inc., a Director at Gaibian Associates Pte Ltd., and an Associate at Harvard University. He previously served as the Chief Executive Officer at ES Cell International Pte Ltd. from 2002 to 2007, the Research Director at PPL Therapeutics Plc from 1987 to 2002, the Director at Singapore Volition Pte Ltd. from 2011 to 2015, the Executive Director at The Singapore Stem Cell Consortium from 2006 to 2013, a Professor-Biochemistry at the University of Birmingham from 1987 to 1992, and a Professor-Regenerative Medicine at King's College London from 2008 to 2009. Dr. Colman received his undergraduate, graduate, and doctorate degrees from the University of Oxford and a doctorate degree from the University of Cambridge. |
| Guy Archibald Innes |
Guy Archibald Innes is an Independent Director at VolitionRX Ltd., a Director at Lignacite Ltd., and an Independent Director at Volition America, Inc. He is also a Member of the Institute of Chartered Accountants in England & Wales. In the past, he served as a Non-Executive Director at ProBio, Inc., Magellan Copper & Gold Plc, and Carbon Mining Plc. He was also a Director at Singapore Volition Pte Ltd. and the Lead Independent Non-Executive Director at VolitionRX Ltd. Additionally, he was the Head-Corporate Finance at Quartz Capital Partners Ltd. He received his undergraduate degree from the University of Bristol. |
| Kim Nguyen |
Kim Nguyen currently works at VolitionRX Ltd., as Independent Director from 2021 and Volition America, Inc., as Independent Director from 2021. Ms. Nguyen also formerly worked at Google Asia Pacific Pte Ltd., as Head-Human Resources from 2017 to 2022 and Binance (Services) Holdings Ltd., as Vice President-International Human Resources. Ms. Nguyen received her undergraduate degree from The University of New South Wales. |
| Mickie Henshall |
Mickie Henshall's current job(s) include being an Independent Director at VolitionRX Ltd. since 2022 and serving as the Chief Marketing Officer at REALM IDx, Inc.Ms. Henshall's former job(s) include working as an Associate Director-Diagnostics Marketing at Illumina, Inc. from 2005 to 2010, Vice President-Marketing at Biotix, Inc. from 2010 to 2014, Vice President-Marketing at Accriva Diagnostics, Inc. from 2014 to 2017, Vice President-Marketing at Agena Bioscience, Inc. from 2017 to 2020, and Chief Marketing Officer at Genomic Life, Inc. in 2020. Ms. Henshall obtained an undergraduate degree from the University of California, Berkeley. |
| Edward W. Futcher |
Edward W. Futcher was the founder of Azima, Inc. (founded in 2003) where he held the title of Vice President-Engineering from 2003 to 2008. He is currently working as an Independent Director at VolitionRX Ltd. (since 2016) and Volition America, Inc. (since 2016). In the past, he worked as an Engineering Director at Infinera Optical Holding, Inc. (1994-1997), Tellabs, Inc. (1994-1997), and InterWAVE Communications International Ltd. (1999-2003) where he held the title of Vice President-Engineering. Dr. Futcher obtained his undergraduate and doctorate degrees from the University of London. |
